🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Active Biotech AB (publ) (STO:ACTI)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.360
-0.145 (-4.14%)
Nov 20, 2026, 5:29 PM CET

Active Biotech AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
12.0612.3613.1713.9415.0615.25
Research & Development
24.3425.2426.6732.5442.8234.54
Operating Expenses
36.437.639.8446.4857.8949.78
Operating Income
-36.4-37.6-39.84-46.48-57.89-49.78
Interest Expense
-0.11-0.11-0.18-0.24-0.21-0.03
Interest & Investment Income
0.430.430.650.290.05-
Currency Exchange Gain (Loss)
-0.04-0.04-0.030.07-0.010.02
EBT Excluding Unusual Items
-35.92-37.32-39.4-46.37-58.05-49.79
Gain (Loss) on Sale of Investments
---0.57-0.32-0.03
Pretax Income
-35.92-37.32-39.4-45.8-58.37-49.83
Net Income
-35.92-37.32-39.4-45.8-58.37-49.83
Net Income to Common
-35.92-37.32-39.4-45.8-58.37-49.83
Net Income Growth
------
Shares Outstanding (Basic)
24134322
Shares Outstanding (Diluted)
24134322
Shares Change
124.10%220.46%54.84%16.21%9.23%26.87%
EPS (Basic)
-1.50-2.77-9.37-16.87-24.98-23.29
EPS (Diluted)
-1.63-3.00-9.37-17.00-25.00-23.29
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EBITDA
-35.1-36-38.24-44.78-57.89-48.48
D&A For EBITDA
1.31.61.61.701.3
EBIT
-36.4-37.6-39.84-46.48-57.89-49.78